ResMed Total Current Liabilities 2010-2024 | RMD

ResMed total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • ResMed total current liabilities for the quarter ending September 30, 2024 were $0.904B, a 17.29% increase year-over-year.
  • ResMed total current liabilities for 2024 were $0.911B, a 20.05% increase from 2023.
  • ResMed total current liabilities for 2023 were $0.759B, a 10.04% increase from 2022.
  • ResMed total current liabilities for 2022 were $0.689B, a 24.4% decline from 2021.
ResMed Annual Total Current Liabilities
(Millions of US $)
2024 $911
2023 $759
2022 $689
2021 $912
2020 $603
2019 $556
2018 $511
2017 $360
2016 $638
2015 $266
2014 $270
2013 $574
2012 $253
2011 $209
2010 $313
2009 $269
ResMed Quarterly Total Current Liabilities
(Millions of US $)
2024-09-30 $904
2024-06-30 $911
2024-03-31 $773
2023-12-31 $764
2023-09-30 $771
2023-06-30 $759
2023-03-31 $762
2022-12-31 $733
2022-09-30 $693
2022-06-30 $689
2022-03-31 $667
2021-12-31 $621
2021-09-30 $624
2021-06-30 $912
2021-03-31 $877
2020-12-31 $577
2020-09-30 $591
2020-06-30 $603
2020-03-31 $552
2019-12-31 $500
2019-09-30 $550
2019-06-30 $556
2019-03-31 $463
2018-12-31 $436
2018-09-30 $421
2018-06-30 $511
2018-03-31 $461
2017-12-31 $1,356
2017-09-30 $352
2017-06-30 $360
2017-03-31 $336
2016-12-31 $682
2016-09-30 $621
2016-06-30 $638
2016-03-31 $287
2015-12-31 $266
2015-09-30 $257
2015-06-30 $266
2015-03-31 $256
2014-12-31 $260
2014-09-30 $254
2014-06-30 $270
2014-03-31 $247
2013-12-31 $243
2013-09-30 $611
2013-06-30 $574
2013-03-31 $580
2012-12-31 $251
2012-09-30 $253
2012-06-30 $253
2012-03-31 $257
2011-12-31 $228
2011-09-30 $226
2011-06-30 $209
2011-03-31 $191
2010-12-31 $247
2010-09-30 $286
2010-06-30 $313
2010-03-31 $325
2009-12-31 $241
2009-09-30 $292
2009-06-30 $269
2009-03-31 $229
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.759B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $203.382B 25.94
Stryker (SYK) United States $148.728B 33.52
Boston Scientific (BSX) United States $134.855B 38.77
EssilorLuxottica (ESLOY) France $111.549B 0.00
Medtronic (MDT) Ireland $108.676B 16.14
Haleon (HLN) United Kingdom $43.230B 28.09
Lonza Group Ag (LZAGY) Switzerland $42.368B 0.00
GE HealthCare Technologies (GEHC) United States $37.464B 19.43
Terumo (TRUMY) Japan $29.367B 41.47
Koninklijke Philips (PHG) Netherlands $24.796B 18.98
Zimmer Biomet Holdings (ZBH) United States $21.580B 13.74
Insulet (PODD) United States $18.378B 73.18
Baxter (BAX) United States $16.844B 10.96
Smith & Nephew SNATS (SNN) United Kingdom $10.947B 0.00
BellRing Brands (BRBR) United States $9.886B 39.63
Bio-Rad Laboratories (BIO) United States $9.115B 30.98
Demant (WILYY) Denmark $8.342B 0.00
Lantheus Holdings (LNTH) United States $6.071B 14.11
TG Therapeutics (TGTX) United States $5.378B 0.00
Haemonetics (HAE) United States $4.291B 20.94
Prestige Consumer Healthcare (PBH) United States $4.157B 20.67
ICU Medical (ICUI) United States $4.134B 39.36
Perrigo (PRGO) Ireland $3.694B 10.88
Envista Holdings (NVST) United States $3.681B 27.42
Agios Pharmaceuticals (AGIO) United States $3.167B 0.00
Neogen (NEOG) United States $3.159B 36.45
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.782B 17.84
QuidelOrtho (QDEL) United States $2.548B 16.40
LeMaitre Vascular (LMAT) United States $2.380B 57.85
Warby Parker (WRBY) United States $2.366B 0.00
Green Thumb Industries (GTBIF) United States $1.977B 34.59
AtriCure (ATRC) United States $1.740B 0.00
InMode (INMD) Israel $1.552B 9.34
AdaptHealth (AHCO) United States $1.331B 9.51
Curaleaf Holdings (CURLF) Canada $1.293B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.253B 0.00
BioLife Solutions (BLFS) United States $1.178B 0.00
Phibro Animal Health (PAHC) United States $0.962B 16.97
Owens & Minor (OMI) United States $0.943B 7.37
National Vision Holdings (EYE) United States $0.910B 30.40
CeriBell (CBLL) United States $0.904B 0.00
Evolus (EOLS) United States $0.826B 0.00
Capricor Therapeutics (CAPR) United States $0.809B 0.00
VAREX IMAGING (VREX) United States $0.679B 30.02
Surmodics (SRDX) United States $0.561B 0.00
Cresco Labs (CRLBF) United States $0.561B 0.00
Verano Holdings (VRNOF) United States $0.554B 0.00
Quanterix (QTRX) United States $0.450B 0.00
Omeros (OMER) United States $0.448B 0.00
Canopy Growth (CGC) Canada $0.407B 0.00
ZimVie (ZIMV) United States $0.379B 31.95
Valneva SE (VALN) France $0.359B 0.00
Viemed Healthcare (VMD) United States $0.339B 32.26
Biote (BTMD) United States $0.334B 7.31
Sanara MedTech (SMTI) United States $0.326B 0.00
Cerus (CERS) United States $0.310B 0.00
OraSure Technologies (OSUR) United States $0.287B 19.25
Zynex (ZYXI) United States $0.258B 54.07
Aurora Cannabis (ACB) Canada $0.236B 0.00
TerrAscend (TSNDF) Canada $0.224B 0.00
Utah Medical Products (UTMD) United States $0.219B 15.12
High Tide (HITI) Canada $0.215B 89.00
MacroGenics (MGNX) United States $0.201B 0.00
Sanuwave Health (SNWV) United States $0.189B 2.67
Jin Medical (ZJYL) China $0.166B 0.00
Organigram Holdings (OGI) Canada $0.164B 0.00
Brainsway (BWAY) Israel $0.164B 98.40
Zevia PBC (ZVIA) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.147B 18.50
TriSalus Life Sciences (TLSI) United States $0.135B 0.00
Fonar (FONR) United States $0.104B 11.75
Quipt Home Medical (QIPT) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 23.10
Veru (VERU) United States $0.092B 0.00
Ayr Wellness (AYRWF) United States $0.079B 0.00
Rockwell Medical (RMTI) United States $0.071B 36.67
Exagen (XGN) United States $0.069B 0.00
Modular Medical (MODD) United States $0.067B 0.00
Cellectar Biosciences (CLRB) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
InterCure (INCR) Israel $0.061B 0.00
MariMed (MRMD) United States $0.059B 0.00
Safety Shot (SHOT) United States $0.053B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Cytosorbents (CTSO) United States $0.049B 0.00
Allurion Technologies (ALUR) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.016B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Senestech (SNES) United States $0.002B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.83
SNDL (SNDL) Canada $0.000B 0.00